FIA
KRRO icon

FNY Investment Advisers’s Korro Bio KRRO Stock Holding History

FNY Investment Advisers’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30
Closed -$2K – 739
2022
Q2 		$2K Buy
30
+4
+15% +$270 ﹤0.01% 578
2022
Q1 		$2K Buy
+26
New +$4.97K ﹤0.01% 625
2021
Q3 		– Sell
-5
Closed -$2K – 823
2021
Q2 		$2K Sell
5
-23
-82% -$11.2K ﹤0.01% 689
2021
Q1 		$13K Buy
+28
New +$54.4K ﹤0.01% 555

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

FNY Investment Advisers's KRRO Position: Q3 2022 in Review

FNY Investment Advisers sold out of Korro Bio (KRRO) in Q3 2022, closing a stake of 30 shares — an estimated $2K sold.

FNY Investment Advisers first reported a position in KRRO in Q1 2021 and held it in 4 quarters. The position peaked at $13K in Q1 2021. 55 funds tracked by Wall St. Rank hold KRRO as of Q3 2022.

  • FNY Investment Advisers reported no remaining Korro Bio position as of Q3 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 30 Korro Bio shares in Q3 2022, an estimated $2K.
  • FNY Investment Advisers first reported a position in Korro Bio in Q1 2021 and held it in 4 quarters.
  • FNY Investment Advisers's Korro Bio position peaked at $13K in Q1 2021.
  • 55 funds tracked by Wall St. Rank held Korro Bio as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.